Health Care·Health Care Equipment·$13.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.42 | N/A | +41.41% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.42 | N/A | +41.41% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed confidence in the company's product demand but acknowledged supply chain issues. They did not provide specific guidance for future quarters.
Management highlighted strong demand for their products.
They noted ongoing challenges in supply chain logistics.
Future growth opportunities were discussed, but no specific guidance was provided.
Insulet Corp reported a strong earnings surprise on EPS, which indicates better-than-expected profitability. However, the stock fell by 1.6% in reaction, likely due to the lack of revenue details and guidance. Investors may be cautious given the ongoing supply chain challenges mentioned by management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
TELADOC HEALTH INC
Feb 22, 2022